§ Funding Round
Series A funding round for Code Biotherapeutics raising $75M in June 2022
Series A funding round for Code Biotherapeutics raising $75M in June 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | ed mathers | |
New Enterprise Associates | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
JDRF T1D Fund | — | — |
UCB Ventures | — | — |
UPMC Enterprises | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$85M
Top Valuation
-
Code Biotherapeutics raised $75M in a Series A round.
The round was announced on 06/01/22.
The round was led by Northpond Ventures.
